“ Critical Evaluation of the off-Label Indication and of the Risks Associated to the Use of Multi-Dose Vials on the Treatment of Age-Related Macular Degeneration ”. Brazilian Journal of Pharmaceutical Sciences 50, no. 1 (March 1, 2014): 63–72. Accessed May 18, 2024. https://www.revistas.usp.br/bjps/article/view/80851.